Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 88

1.

Combination epidermal growth factor receptor variant III peptide-pulsed dendritic cell vaccine with miR-326 results in enhanced killing on EGFRvIII-positive cells.

Li J, Wang F, Wang G, Sun Y, Cai J, Liu X, Zhang J, Lu X, Li Y, Chen M, Chen L, Jiang C.

Oncotarget. 2017 Apr 18;8(16):26256-26268. doi: 10.18632/oncotarget.15445.

2.

Topical and systemic immunoreaction triggered by intravesical chemotherapy in an N-butyl-N-(4-hydroxybutyl) nitorosamine induced bladder cancer mouse model.

Hori S, Miyake M, Tatsumi Y, Onishi S, Morizawa Y, Nakai Y, Tanaka N, Fujimoto K.

PLoS One. 2017 Apr 13;12(4):e0175494. doi: 10.1371/journal.pone.0175494. eCollection 2017.

3.

The differentiation and plasticity of Tc17 cells are regulated by CTLA-4-mediated effects on STATs.

Arra A, Lingel H, Kuropka B, Pick J, Schnoeder T, Fischer T, Freund C, Pierau M, Brunner-Weinzierl MC.

Oncoimmunology. 2017 Jan 20;6(2):e1273300. doi: 10.1080/2162402X.2016.1273300. eCollection 2017.

PMID:
28344884
4.

IL-17A levels in systemic lupus erythematosus associated with inflammatory markers and lower rates of malignancy and heart damage: Evidence for a dual role.

Raymond W, Ostli-Eilertsen G, Griffiths S, Nossent J.

Eur J Rheumatol. 2017 Mar;4(1):29-35. doi: 10.5152/eurjrheum.2017.16059. Epub 2017 Mar 1.

5.

Expression of Th1- Th2- and Th17-associated cytokines in laryngeal carcinoma.

Xu X, Wang R, Su Q, Huang H, Zhou P, Luan J, Liu J, Wang J, Chen X.

Oncol Lett. 2016 Sep;12(3):1941-1948. Epub 2016 Jul 13.

6.

Nrf2 Induces IL-17D to Mediate Tumor and Virus Surveillance.

Saddawi-Konefka R, Seelige R, Gross ET, Levy E, Searles SC, Washington A Jr, Santosa EK, Liu B, O'Sullivan TE, Harismendy O, Bui JD.

Cell Rep. 2016 Aug 30;16(9):2348-58. doi: 10.1016/j.celrep.2016.07.075. Epub 2016 Aug 18.

7.

BET bromodomain proteins and epigenetic regulation of inflammation: implications for type 2 diabetes and breast cancer.

Nicholas DA, Andrieu G, Strissel KJ, Nikolajczyk BS, Denis GV.

Cell Mol Life Sci. 2017 Jan;74(2):231-243. doi: 10.1007/s00018-016-2320-0. Epub 2016 Aug 4. Review.

PMID:
27491296
8.

Elevated IL-17 and TGF-β Serum Levels: A Positive Correlation between T-helper 17 Cell-Related Pro-Inflammatory Responses with Major Depressive Disorder.

Davami MH, Baharlou R, Ahmadi Vasmehjani A, Ghanizadeh A, Keshtkar M, Dezhkam I, Atashzar MR.

Basic Clin Neurosci. 2016 Apr;7(2):137-42. doi: 10.15412/J.BCN.03070207.

9.

Reduced levels of T-helper 17-associated cytokines in the serum of patients with breast cancer: indicators for following the course of disease.

Baharlou R, Atashzar MR, Vasmehjani AA, Rahimi E, Khoshmirsafa M, Seif F, Mahdiyar M.

Cent Eur J Immunol. 2016;41(1):78-85. doi: 10.5114/ceji.2016.58819. Epub 2016 Mar 24.

10.

Interleukin-17 Could Promote Breast Cancer Progression at Several Stages of the Disease.

Welte T, Zhang XH.

Mediators Inflamm. 2015;2015:804347. doi: 10.1155/2015/804347. Epub 2015 Dec 13. Review.

11.

Cancer stem cell targeted therapy: progress amid controversies.

Wang T, Shigdar S, Gantier MP, Hou Y, Wang L, Li Y, Shamaileh HA, Yin W, Zhou SF, Zhao X, Duan W.

Oncotarget. 2015 Dec 29;6(42):44191-206. doi: 10.18632/oncotarget.6176. Review.

12.

Prognostic significance of interleukin-17 in solid tumors: a meta-analysis.

Zeng Y, Zhang Q, Wang H, Lu M, Kong H, Zhang Y, Shi H.

Int J Clin Exp Med. 2015 Jul 15;8(7):10515-36. eCollection 2015.

13.

High throughput screening of cytokines, chemokines and matrix metalloproteinases in wound fluid induced by mammary surgery.

Wang D, Hu K, Gao N, Zhang H, Jiang Y, Liu C, Wang S, Zhao Z.

Oncotarget. 2015 Oct 6;6(30):29296-310. doi: 10.18632/oncotarget.4828.

14.

Characterization and Clinical Implication of Th1/Th2/Th17 Cytokines Produced from Three-Dimensionally Cultured Tumor Tissues Resected from Breast Cancer Patients.

Kiyomi A, Makita M, Ozeki T, Li N, Satomura A, Tanaka S, Onda K, Sugiyama K, Iwase T, Hirano T.

Transl Oncol. 2015 Aug;8(4):318-26. doi: 10.1016/j.tranon.2015.06.004.

15.

Blockade of Wnt/β-catenin signaling suppresses breast cancer metastasis by inhibiting CSC-like phenotype.

Jang GB, Kim JY, Cho SD, Park KS, Jung JY, Lee HY, Hong IS, Nam JS.

Sci Rep. 2015 Jul 23;5:12465. doi: 10.1038/srep12465.

16.

IL-17A and its homologs IL-25/IL-17E recruit the c-RAF/S6 kinase pathway and the generation of pro-oncogenic LMW-E in breast cancer cells.

Mombelli S, Cochaud S, Merrouche Y, Garbar C, Antonicelli F, Laprevotte E, Alberici G, Bonnefoy N, Eliaou JF, Bastid J, Bensussan A, Giustiniani J.

Sci Rep. 2015 Jul 8;5:11874. doi: 10.1038/srep11874.

17.
18.

Increased interleukin-17 transcripts in peripheral blood mononuclear cells, a link between T-helper 17 and proinflammatory responses in bladder cancer.

Baharlou R, Khezri A, Razmkhah M, Habibagahi M, Hosseini A, Ghaderi A, Jaberipour M.

Iran Red Crescent Med J. 2015 Feb 3;17(2):e9244. doi: 10.5812/ircmj.9244. eCollection 2015 Feb.

19.

Tumor cell secretion of soluble factor(s) for specific immunosuppression.

Kano A.

Sci Rep. 2015 Mar 9;5:8913. doi: 10.1038/srep08913.

20.

Role of IL-17 in Glioma Progression.

Parajuli P, Mittal S.

J Spine Neurosurg. 2013 Oct 18;Suppl 1. pii: S1-004.

Supplemental Content

Support Center